Search Results
Investigating the safety and efficacy of re-treating CLL patients with venetoclax-based regimens
A retrospective study of venetoclax re-treatment in CLL patients
The long-term efficacy of acalabrutinib-based regimens in patients with CLL
Treating CLL after venetoclax or BTK inhibitors
TLS in patients with CLL treated with venetoclax
Debulking regimens prior to venetoclax therapy in CLL
The role of venetoclax in the treatment of CLL
5-year follow-up results of CLL14: obinutuzumab + venetoclax vs obinutuzumab + chlorambucil in CLL
Cessation of venetoclax and remaining in remission from CLL?
MAJIC: Venetoclax with acalabrutinib or obinutuzumab in CLL
Venetoclax Resistance: Mechanisms and Treatment Options
Matthew Davids, MD, MMSc, on His Hopes for CLL Treatment, Research in 2023
